KalVista Pharmaceuticals
Tracked across 1 events · 20 articles · First seen May 19, 2026 · Last active Jun 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: KalVista Pharmaceuticals, Inc. is under investigation by Halper Sadeh LLC concerning its sale to Chiesi Farmaceutici for $27.00 per share, with potential violations of federal securities laws.
May 19, 2026 · 20 articles
ERGEN INTELLIGENCE
Track KalVista Pharmaceuticals live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard